Chapter 18: Biopsychology of Psychiatric Disorders

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/57

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

58 Terms

1
New cards

Active placebos

substances that produce side effects similar to those of the active drug being tested, used to control for the psychological effects of believing one is receiving treatment.

2
New cards

Agoraphobia

a type of anxiety disorder characterized by an intense fear of being in situations where escape might be difficult, often leading to avoidance of public spaces.

3
New cards

Anxiety

a psychological condition marked by excessive worry, fear, and apprehension, often involving physical symptoms like rapid heartbeat and sweating.

4
New cards

Anxiety disorder

a group of mental health disorders characterized by significant and persistent feelings of anxiety, fear, or panic that interfere with daily activities.

5
New cards

anxiolytic drugs

medications that alleviate anxiety by acting on the central nervous system, often prescribed for anxiety disorders.

6
New cards

atypical antidepressants

a class of antidepressant medications that do not fit neatly into the traditional categories of serotonin reuptake inhibitors or tricyclics, often used to treat major depressive disorder and anxiety disorders.

7
New cards

Atypical antipsychotics

a class of medications used to manage psychosis, particularly in disorders such as schizophrenia and bipolar disorder. They work by altering the effects of neurotransmitters in the brain.

8
New cards

bipolar disorder

a mental health condition characterized by significant mood swings, including emotional highs (mania or hypomania) and lows (depression).

9
New cards

Bipolar disorder type I

is defined by manic episodes that last at least seven days or by manic symptoms that are so severe that immediate hospital care is needed. Depressive episodes often occur as well, typically lasting at least two weeks.

10
New cards

Bipolar disorder type II

is characterized by a pattern of depressive episodes and hypomanic episodes, but not the full-blown manic episodes found in type I. The hypomanic episodes are less severe and shorter in duration.

11
New cards

Butyrophenones

are a class of antipsychotic medications used to treat mental health conditions, including schizophrenia and acute psychosis. They work by blocking dopamine receptors in the brain.

12
New cards

cheese effect

is a phenomenon associated with the use of certain antipsychotic medications, particularly butyrophenones, where patients experience a rapid return of psychotic symptoms if they consume certain foods, notably those containing high levels of tyramine.

13
New cards

chlorpromazine

is an antipsychotic medication of the phenothiazine class, primarily used to treat schizophrenia and severe behavioral problems. It works by modulating the effects of neurotransmitters in the brain, particularly dopamine.

14
New cards

clinical depression

is a mood disorder characterized by persistent feelings of sadness, loss of interest in activities, and various emotional and physical problems that can affect daily functioning.

15
New cards

clinical trials

studies conducted on human subjects to assess the therapeutic efficacy of an untested drug or other treatment

16
New cards

clozapine

is an antipsychotic medication used primarily for treatment-resistant schizophrenia. It works by blocking certain dopamine receptors and is also effective in reducing suicidal thoughts in patients with schizophrenia.

17
New cards

comorbid

referring to the presence of one or more additional disorders co-occurring with a primary disorder in a patient.

18
New cards

defensive-burying test

is a behavioral test used to assess anxiety and stress responses in animals, where they bury objects as a defensive mechanism.

19
New cards

DSM-5

is the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association, which classifies and provides diagnostic criteria for mental health disorders.

20
New cards

elevated-plus-maze test

is a widely used experimental method for assessing anxiety in animals, consisting of a plus-shaped platform with two open arms and two enclosed arms, allowing researchers to observe avoidance behavior.

21
New cards

endogenous depression

is a type of depression that arises without an apparent external cause, often linked to biological factors such as neurotransmitter imbalances or genetic predisposition.

22
New cards

euthymic

describes a mental state characterized by a stable, normal mood and absence of significant depression or mania.

23
New cards

fluoxetine

is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed to treat depression and anxiety disorders by increasing serotonin levels in the brain.

24
New cards

generalized anxiety disorder

is a mental health condition characterized by excessive, uncontrollable worry and anxiety about various aspects of daily life, often accompanied by physical symptoms such as restlessness or fatigue.

25
New cards

haloperidol

is an antipsychotic medication used primarily to treat schizophrenia and acute psychosis by blocking dopamine receptors in the brain.

26
New cards

Hypomania

is a mood state characterized by periods of elevated or irritable mood, increased energy, and hyperactivity, but to a lesser degree than full mania. It is often associated with bipolar disorder.

27
New cards

Imipramine

is a tricyclic antidepressant used to treat depression and anxiety disorders by affecting neurotransmitters in the brain, specifically serotonin and norepinephrine.

28
New cards

Iproniazid

is a monoamine oxidase inhibitor (MAOI) used primarily as an antidepressant. It works by preventing the breakdown of neurotransmitters such as serotonin and norepinephrine, thereby alleviating symptoms of depression.

29
New cards

ketamine

is a dissociative anesthetic that has gained attention for its rapid-acting antidepressant effects in treatment-resistant depression. It modulates glutamate activity in the brain, leading to increased synaptic connectivity.

30
New cards

Lithium

is a mood stabilizer commonly used to treat bipolar disorder. It helps to reduce the frequency and severity of manic and depressive episodes by influencing neurotransmitter systems in the brain.

31
New cards

lysergic acid diethylamide

(LSD) is a powerful hallucinogenic drug known for its ability to alter perception, mood, and cognitive processes. It primarily acts on serotonin receptors in the brain, leading to significant changes in sensory perception.

32
New cards

Mania

is a state characterized by elevated mood, increased energy, hyperactivity, and impulsive behavior. It is often associated with bipolar disorder and can lead to significant impairment in functioning.

33
New cards

MAO inhibitors

are a class of antidepressant medications that work by inhibiting the enzyme monoamine oxidase, which is responsible for breaking down neurotransmitters such as serotonin, norepinephrine, and dopamine, thereby increasing their levels in the brain.

34
New cards

mixed state

describes a condition where features of both mania and depression occur simultaneously, leading to unpredictable moods and behaviors. This state is often challenging to diagnose and treat.

35
New cards

mood stabilizers

are medications used to reduce mood swings and stabilize emotional states, particularly in conditions like bipolar disorder.

36
New cards

negative symptoms

refers to deficits or decreases in emotional expression, motivation, and social engagement commonly associated with schizophrenia, such as lack of pleasure in everyday activities.

37
New cards

orphan drugs

are medications developed specifically to treat rare diseases that may not be financially viable for pharmaceutical companies to produce.

38
New cards

panic attacks

are sudden episodes of intense fear or discomfort that reach a peak within minutes, often accompanied by physical symptoms such as heart palpitations, shortness of breath, and dizziness.

39
New cards

panic disorder

a mental health condition characterized by recurrent and unexpected panic attacks, often leading to significant anxiety about future attacks and avoidance of certain situations.

40
New cards

peripartum depression

a type of major depressive episode that occurs during pregnancy or within the first year after childbirth, affecting the mother's mood, behavior, and overall well-being.

41
New cards

phenothiazines

a class of antipsychotic medications used to treat schizophrenia and other severe mental health disorders by blocking dopamine receptors in the brain.

42
New cards

positive symptoms

Symptoms of schizophrenia that add to a person's behavior, including hallucinations, delusions, and disorganized thinking.

43
New cards

psychedelic drugs

substances that alter perception, mood, and cognitive processes, often inducing visual and auditory hallucinations.

44
New cards

psychiatric disorder

A mental health condition characterized by alterations in thinking, mood, or behavior that impair daily functioning or well-being.

45
New cards

psychosis

a severe mental disorder characterized by a disconnection from reality, which may manifest as hallucinations or delusions.

46
New cards

reactive depression

A type of depression triggered by a specific external event or stressor, often leading to feelings of sadness or hopelessness.

47
New cards

repetitive transcranial magnetic stimulation

A non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain, often used to treat depression when other treatments have failed.

48
New cards

reserpine

a medication that affects neurotransmitter levels in the brain, historically used to treat high blood pressure and sometimes prescribed for anxiety and certain psychiatric disorders.

49
New cards

risk-assessment test

A tool used to evaluate the likelihood of a person developing a psychiatric disorder or experiencing a specific adverse event based on various risk factors.

50
New cards

seasonal affective disorder

A type of depression that occurs at certain times of the year, typically in the winter months, characterized by changes in mood, sleep, and energy levels.

51
New cards

selective serotonin-reuptake inhibitors

(SSRIs) are a class of antidepressant medications that increase serotonin levels in the brain by inhibiting its reabsorption in synapses, commonly used to treat depression and anxiety disorders.

52
New cards

specific phobia

An intense, irrational fear of a specific object or situation that leads to avoidance behavior and significant distress.

53
New cards

tics

involuntary, repetitive movements or sounds, often associated with disorders such as Tourette syndrome.

54
New cards

tourette’s disorder

A neurological disorder characterized by multiple motor tics and one or more vocal tics that persist for more than a year.

55
New cards

translational bottleneck

The difficulty of translating basic research findings into effective treatments in clinical settings.

56
New cards

tricyclic antidepressants

A class of medications used primarily to treat depression by inhibiting the reuptake of neurotransmitters such as norepinephrine and serotonin.

57
New cards

typical antipsychotics

are a class of medications used to manage psychosis, particularly in schizophrenia and bipolar disorder, by blocking dopamine receptors in the brain.

58
New cards

Up-regulation

The process by which a cell increases the quantity of a cellular component, such as proteins or neurotransmitter receptors, in response to an increase in the availability of certain signals or stimuli.